NCT05216952View on ClinicalTrials.gov

Ulipristal Acetate for Use in Early Pregnancy Loss

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 11, 2022

Primary Completion Date

January 3, 2023

Study Completion Date

April 30, 2023

Conditions
Missed AbortionAnembryonic PregnancyNon-Viable Pregnancy
Interventions
DRUG

Ulipristal Acetate Tablets

90mg (three 30mg tablets) administered orally once

DRUG

Misoprostol Pill

800mcg (four 200mcg pills) administered vaginally once 6-18 hours following ulipristal acetate

Trial Locations (4)

27278

University of North Carolina, Chapel Hill - Hillsborough Medical Office Building, Hillsborough

27514

University of North Carolina, Chapel Hill - Same Day OBGYN Clinic, Chapel Hill

University of North Carolina, Chapel Hill - Vilcom Center, Chapel Hill

University of North Carolina, Chapel Hill - Weaver Crossing, Chapel Hill

All Listed Sponsors
collaborator

North Carolina Translational and Clinical Sciences Institute

OTHER

lead

University of North Carolina, Chapel Hill

OTHER